BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36357765)

  • 21. Correlation of Crtc1/3-Maml2 fusion status, grade and survival in mucoepidermoid carcinoma.
    Birkeland AC; Foltin SK; Michmerhuizen NL; Hoesli RC; Rosko AJ; Byrd S; Yanik M; Nor JE; Bradford CR; Prince ME; Carey TE; McHugh JB; Spector ME; Brenner JC
    Oral Oncol; 2017 May; 68():5-8. PubMed ID: 28438292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of amphiregulin in mucoepidermoid carcinoma of the major salivary glands: a molecular and clinicopathological study.
    Shinomiya H; Ito Y; Kubo M; Yonezawa K; Otsuki N; Iwae S; Inagaki H; Nibu KI
    Hum Pathol; 2016 Nov; 57():37-44. PubMed ID: 27393417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new type of MAML2 fusion in mucoepidermoid carcinoma.
    Fehr A; Röser K; Heidorn K; Hallas C; Löning T; Bullerdiek J
    Genes Chromosomes Cancer; 2008 Mar; 47(3):203-6. PubMed ID: 18050304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [MAML2 gene rearrangement, fusion patterns and clinicopathological characteristics in primary pulmonary mucoepidermoid carcinoma].
    Zhang X; Bai QM; Yao QL; Ji G; Chang H; Han J; Li Y; Ji Y; Hou YY; Zhou XY
    Zhonghua Bing Li Xue Za Zhi; 2021 Aug; 50(8):891-898. PubMed ID: 34344072
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinicopathological significance of EGFR pathway gene mutations and CRTC1/3-MAML2 fusions in salivary gland mucoepidermoid carcinoma.
    Morita M; Murase T; Okumura Y; Ueda K; Sakamoto Y; Masaki A; Kawakita D; Tada Y; Nibu KI; Shibuya Y; Inagaki H
    Histopathology; 2020 Jun; 76(7):1013-1022. PubMed ID: 32129900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomic profiles and CRTC1-MAML2 fusion distinguish different subtypes of mucoepidermoid carcinoma.
    Jee KJ; Persson M; Heikinheimo K; Passador-Santos F; Aro K; Knuutila S; Odell EW; Mäkitie A; Sundelin K; Stenman G; Leivo I
    Mod Pathol; 2013 Feb; 26(2):213-22. PubMed ID: 23018873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CRTC1 rearrangements in the absence of t(11;19) in primary cutaneous mucoepidermoid carcinoma.
    Lennerz JK; Perry A; Dehner LP; Pfeifer JD; Lind AC
    Br J Dermatol; 2009 Oct; 161(4):925-9. PubMed ID: 19438452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sclerosing Mucoepidermoid Carcinoma in the Parotid Gland With CRTC1-MAML2 Fusion: A Case Report.
    Yabuki K; Matsuyama A; Shiba E; Nagatani G; Hisaoka M
    Int J Surg Pathol; 2018 May; 26(3):250-255. PubMed ID: 29169286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of CRTC1/3-MAML2 fusions on histological classification and prognosis of mucoepidermoid carcinoma.
    Okumura Y; Miyabe S; Nakayama T; Fujiyoshi Y; Hattori H; Shimozato K; Inagaki H
    Histopathology; 2011 Jul; 59(1):90-7. PubMed ID: 21668476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A link between the expression of the stem cell marker HMGA2, grading, and the fusion CRTC1-MAML2 in mucoepidermoid carcinoma.
    Fehr A; Meyer A; Heidorn K; Röser K; Löning T; Bullerdiek J
    Genes Chromosomes Cancer; 2009 Sep; 48(9):777-85. PubMed ID: 19521953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic impact of CRTC1/3-MAML2 fusions in salivary gland mucoepidermoid carcinoma: A multiinstitutional retrospective study.
    Okumura Y; Nakano S; Murase T; Ueda K; Kawakita D; Nagao T; Kusafuka K; Urano M; Yamamoto H; Kano S; Tsukahara K; Okami K; Nagao T; Hanai N; Iwai H; Kawata R; Tada Y; Nibu KI; Inagaki H
    Cancer Sci; 2020 Nov; 111(11):4195-4204. PubMed ID: 32860299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncocytic mucoepidermoid carcinoma of the parotid gland with CRTC1-MAML2 fusion transcript: report of a case with review of literature.
    Fujimaki M; Fukumura Y; Saito T; Mitani K; Uchida S; Yokoyama J; Yao T; Ikeda K
    Hum Pathol; 2011 Dec; 42(12):2052-5. PubMed ID: 21676434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unfavorable prognosis of CRTC1-MAML2 positive mucoepidermoid tumors with CDKN2A deletions.
    Anzick SL; Chen WD; Park Y; Meltzer P; Bell D; El-Naggar AK; Kaye FJ
    Genes Chromosomes Cancer; 2010 Jan; 49(1):59-69. PubMed ID: 19827123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. t(11;19) translocation and CRTC1-MAML2 fusion oncogene in mucoepidermoid carcinoma.
    O'Neill ID
    Oral Oncol; 2009 Jan; 45(1):2-9. PubMed ID: 18486532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary intraosseous mucoepidermoid carcinoma of the jaw: Reappraisal of The MD Anderson Cancer Center experience.
    Bell D; Lewis C; El-Naggar AK; Weber RS
    Head Neck; 2016 Apr; 38 Suppl 1():E1312-7. PubMed ID: 26316332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CRTC1-MAML2 gene fusion in mucoepidermoid carcinoma of the lacrimal gland.
    Von Holstein SL; Fehr A; Heegaard S; Therkildsen MH; Stenman G
    Oncol Rep; 2012 May; 27(5):1413-6. PubMed ID: 22323114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Central mucoepidermoid carcinoma arising directly from a glandular odontogenic cyst of the mandible: a case report.
    Maruyama S; Mori T; Yamazaki M; Abé T; Ryo E; Kano H; Hasegawa G; Tanuma JI
    Diagn Pathol; 2021 Jul; 16(1):61. PubMed ID: 34247629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of p27Kip1, Ki-67, and CRTC1-MAML2 fusion transcript in mucoepidermoid carcinoma: a molecular and clinicopathologic study of 101 cases.
    Miyabe S; Okabe M; Nagatsuka H; Hasegawa Y; Inagaki A; Ijichi K; Nagai N; Eimoto T; Yokoi M; Shimozato K; Inagaki H
    J Oral Maxillofac Surg; 2009 Jul; 67(7):1432-41. PubMed ID: 19531414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Warthin-like Mucoepidermoid Carcinoma: A Combined Study of Fluorescence In Situ Hybridization and Whole-slide Imaging.
    Ishibashi K; Ito Y; Masaki A; Fujii K; Beppu S; Sakakibara T; Takino H; Takase H; Ijichi K; Shimozato K; Inagaki H
    Am J Surg Pathol; 2015 Nov; 39(11):1479-87. PubMed ID: 26457352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gefitinib as targeted therapy for mucoepidermoid carcinoma of the lung: possible significance of CRTC1-MAML2 oncogene.
    O'Neill ID
    Lung Cancer; 2009 Apr; 64(1):129-30. PubMed ID: 19185385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.